Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Timothy Pollak

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|August 25, 2016
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac ArrestP Timothy Pollak, J David Spence
Journal of Clinical Pharmacology|January 30, 2004
Teaching application of clinical pharmacology skills using unusual observations from clozapine overdosesP Timothy Pollak, Steven L Shafer
American Journal of Respiratory and Critical Care Medicine|February 28, 2022
Why Would Physiologic Support with Continuous Positive Airway Pressure Not Improve Outcomes in Patients with Atrial Fibrillation with Sleep Apnea?Kathryn M Lalonde, P Timothy Pollak, Marcus Povitz
Current Vascular Pharmacology|August 5, 2008
Amiodarone hepatotoxicityMohamed Babatin, Samuel S Lee, P Timothy Pollak
The Canadian Journal of Cardiology|April 17, 2022
Correlation of Serum Alanine Transaminase With Amiodarone Parent and Metabolite Concentrations Persists for 16 Years of Follow-upSyed Qutb Shah, Satish R Raj, P Timothy Pollak
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 13, 2011
Falling between the cracks: a case of amiodarone toxicityConstanze Mackenzie, Jaffer Syed, P Timothy Pollak, et al.
Journal of Clinical Pharmacology|July 29, 2010
Risperidone-induced QT prolongation following overdose correlates with serum drug concentration and resolves rapidly with no evidence of altered pharmacokineticsP Timothy Pollak, Zulfikaral H Verjee, Andrew W Lyon
The Canadian Journal of Cardiology|February 4, 2018
Personalized Anticoagulation: Guided Apixaban Dose Adjustment to Compensate for Pharmacokinetic Abnormalities Related to Short-Bowel SyndromeP Timothy Pollak, Gavin R Sun, Richard B Kim
Pharmacological Research|July 27, 2010
Influence of peroxisome proliferator-activated receptor-alpha (PPARα) activity on adverse effects associated with amiodarone exposure in miceMatthew C Ernst, Christopher J Sinal, P Timothy Pollak
CJC Open|March 12, 2020
Treatment Decisions in Geriatric Cardiac Lymphoma Facilitated by Serial Cardiac Magnetic Resonance Imaging and Positron Emission TomographyP Timothy Pollak, Gurbir Brar, Krishna Poinen, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|August 25, 2016
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac ArrestP Timothy Pollak, J David Spence
Journal of Clinical Pharmacology|January 30, 2004
Teaching application of clinical pharmacology skills using unusual observations from clozapine overdosesP Timothy Pollak, Steven L Shafer
American Journal of Respiratory and Critical Care Medicine|February 28, 2022
Why Would Physiologic Support with Continuous Positive Airway Pressure Not Improve Outcomes in Patients with Atrial Fibrillation with Sleep Apnea?Kathryn M Lalonde, P Timothy Pollak, Marcus Povitz
Current Vascular Pharmacology|August 5, 2008
Amiodarone hepatotoxicityMohamed Babatin, Samuel S Lee, P Timothy Pollak
The Canadian Journal of Cardiology|April 17, 2022
Correlation of Serum Alanine Transaminase With Amiodarone Parent and Metabolite Concentrations Persists for 16 Years of Follow-upSyed Qutb Shah, Satish R Raj, P Timothy Pollak
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 13, 2011
Falling between the cracks: a case of amiodarone toxicityConstanze Mackenzie, Jaffer Syed, P Timothy Pollak, et al.
Journal of Clinical Pharmacology|July 29, 2010
Risperidone-induced QT prolongation following overdose correlates with serum drug concentration and resolves rapidly with no evidence of altered pharmacokineticsP Timothy Pollak, Zulfikaral H Verjee, Andrew W Lyon
The Canadian Journal of Cardiology|February 4, 2018
Personalized Anticoagulation: Guided Apixaban Dose Adjustment to Compensate for Pharmacokinetic Abnormalities Related to Short-Bowel SyndromeP Timothy Pollak, Gavin R Sun, Richard B Kim
Pharmacological Research|July 27, 2010
Influence of peroxisome proliferator-activated receptor-alpha (PPARα) activity on adverse effects associated with amiodarone exposure in miceMatthew C Ernst, Christopher J Sinal, P Timothy Pollak
CJC Open|March 12, 2020
Treatment Decisions in Geriatric Cardiac Lymphoma Facilitated by Serial Cardiac Magnetic Resonance Imaging and Positron Emission TomographyP Timothy Pollak, Gurbir Brar, Krishna Poinen, et al.
Pageof 3